Ivermectin: facts and science are in its favour – Dr Rapiti

Loading player...
In August 2021, BizNews conducted a panel discussion with Professor Colleen Aldous, Dr Nathi Mdladla and Dr Pinky Ngcakani – all of whom are strongly in favour of ivermectin. The discussion was published on BizNews TV on YouTube and for a year, it managed to evade the YouTube censorship police. Last week, Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects showed that Regular Use of Ivermectin as Prophylaxis for COVID-19 led to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner. First thing this morning, BizNews received notification of a strike on our BizNews TV YouTube channel on account of the ivermectin panel discussion, which was taken down. The timing appears too odd for coincidence. What may be more realistic is that the World Health Organisation, which is in close ‘cahoots’ with YouTube, is doing a sweep of all pro-ivermectin content. This is the original ivermectin panel discussion podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices
5 Sep 2022 11AM English South Africa Investing · Business News

Other recent episodes

The NdB Sunday Show | What Cyril knew before the Mkhwanazi presser…

In this edition of the NdB Sunday Show, Chris Steyn and independent intelligence analyst Jasmine Opperman talk about testimony at the Madlanga Commission of Inquiry that - six days before whistleblowing General Nhlanhla Mkhwanazi called his bombshell press conference - President Cyril Ramaphosa had a verbal intelligence briefing in which…
15 Nov 7AM 34 min

BN Edge | Piet le Roux: ICASA, Starlink and the true cost of BEE

To sell internet access in South Africa, you first have to show ICASA the race of your shareholders. Sakeliga has now taken the regulator to the Pretoria High Court, but, oddly, not to scrap the 30% black-ownership rule. Chief executive Piet le Roux told Alec Hogg why he chose the…
13 Nov 6AM 28 min